SKIN & AESTHETICS RESEARCH / FAQ
Questions People Actually Ask
Direct, citation-anchored answers about GHK-Cu, the GLOW blend, and Melanotan II.
What does a GHK-Cu peptide do?
GHK-Cu is a copper-binding tripeptide studied for its effects on skin structure. It stimulates skin cells to produce more collagen, elastin, and other structural proteins, and it delivers copper needed for the enzyme that cross-links those proteins into a firm matrix. In small human trials, topical GHK-Cu increased procollagen synthesis in about 70% of subjects, compared with 50% for vitamin C and 40% for retinoic acid tested the same way [1]. It is also studied for hair growth, wound healing, and — separately from skin — a broad set of gene-expression effects tied to tissue repair [2].
What is GHK-Cu and how does it work?
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a sequence found naturally in human collagen and plasma. It works two ways at once: as a copper chaperone, it enables the enzyme (lysyl oxidase) that cross-links collagen and elastin into strong tissue, and as a signaling molecule, it appears to shift gene expression toward repair, antioxidant, and DNA-repair programs and away from inflammation [2]. Its natural presence in the body, combined with a long cosmetic safety record as topical Copper Tripeptide-1, is why it has a more established research base than most peptides studied for skin.
Is GHK-Cu peptide really anti-aging?
The research supports specific, measured effects rather than a blanket "anti-aging" claim. Controlled comparisons have found GHK-Cu increases procollagen synthesis more consistently than vitamin C or retinoic acid in the same test, and a separate controlled trial of a GHK-containing combination product produced a statistically significant increase in hair count over placebo [1][3]. That is real evidence for specific structural and follicular effects — it is not the same as a proven, comprehensive reversal of skin aging, and much of the broader anti-aging literature is preclinical or comes from a small number of research groups, which this site treats as a reason for calibrated confidence rather than either dismissal or hype [4].
What is the difference between GHK and GHK-Cu?
GHK is the bare tripeptide (glycine-histidine-lysine) without any metal attached. GHK-Cu is that same tripeptide bound to a copper ion. The distinction matters because most of the documented tissue-remodeling activity — the collagen and elastin stimulation described throughout this site — depends specifically on the copper being bound; laboratory work shows the copper-free peptide does not reproduce key effects such as stimulation of certain matrix-remodeling enzymes on its own. Products or literature that use "GHK" and "GHK-Cu" interchangeably are conflating two chemically distinct things, and this site is careful to specify which one a given finding applies to.
What is GLOW peptide?
GLOW is a supplier- or clinic-formulated combination of three separate peptides — most commonly GHK-Cu, BPC-157, and TB-500 — sold together as one product on the theory that their individual research mechanisms complement each other for skin and tissue repair. It is not a single molecule and has never been tested as a combined product in a clinical trial; a 2026 review that names all three ingredients together concludes that rigorous human safety data for compounds like these remain scarce [8].
What does the GLOW peptide do?
Individually, its three ingredients are studied for different things: GHK-Cu for collagen and matrix stimulation [4], BPC-157 for blood-vessel-supporting (angiogenic) and protective effects via the VEGFR2 pathway [10], and TB-500 (via its parent protein thymosin beta-4) for cell migration and reduced scarring. The combination's marketed effect — an overall skin "glow" plus faster-looking tissue repair — is extrapolated from those separate mechanisms; no study has tested whether the blend actually produces that combined result.
What does GLOW peptide have in it?
A commonly cited GLOW research-label ratio is roughly 10 mg BPC-157, 10 mg TB-500, and 50 mg GHK-Cu per vial, though exact ratios and purity are formulation-specific and not standardized across suppliers. Because there is no regulatory body confirming what any given vial actually contains, the labeled ratio should be understood as a stated formulation, not a verified one.
What peptides are in the GLOW blend?
The three most commonly cited ingredients are GHK-Cu (a copper-binding tripeptide, covered in full on this site's GHK-Cu page), BPC-157 (a synthetic 15-amino-acid fragment derived from a gastric protective protein), and TB-500 (an acetylated 7-amino-acid fragment of thymosin beta-4, a cell-migration and repair protein). See the full GLOW page for how their individual mechanisms are thought to complement each other.
What is Melanotan 2?
Melanotan II is a synthetic, cyclic seven-amino-acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH), designed in the late 1980s to be more potent and longer-lasting than the natural hormone. It is studied for its effects on skin pigmentation and, separately, appetite and sexual response, but it has never been approved by the FDA or any other regulator for any use [14].
What is Melanotan 2 used for in research?
Published research has studied Melanotan II's effects on skin pigmentation, appetite suppression, and erectile response. A small, controlled crossover trial in 10 men with psychogenic erectile dysfunction found it produced clinically apparent erections in 8 of 10 men, with substantially longer duration than placebo [15]. Separately, animal studies show it reduces food intake and food-seeking behavior through melanocortin receptors in the brain [12]. It also carries an extensive published case-report literature documenting serious adverse events, including melanoma, kidney injury, and priapism [11][13].
How does Melanotan 2 work in the body?
Melanotan II is a non-selective agonist of the melanocortin receptor family. Activating MC1R on skin pigment cells (melanocytes) triggers the melanogenesis cascade described below, darkening skin and hair without UV exposure. Activating MC3R and MC4R in the brain, particularly the hypothalamus, is what underlies its appetite-suppressing and pro-sexual effects. Because it activates several receptors at once rather than one selectively, a single dose can affect pigmentation, appetite, and sexual response simultaneously.
What is the melanogenesis (MC1R-cAMP-MITF) signaling cascade?
It is the chain of signaling events inside a pigment cell that produces more pigment. When a melanocortin (either the body's natural alpha-MSH or a synthetic analog like Melanotan II) activates the MC1R receptor on a melanocyte's surface, it raises the level of a signaling molecule called cAMP inside the cell. That activates an enzyme (PKA), which in turn activates a gene-regulating protein (CREB), which increases production of a master pigmentation-control protein called MITF. MITF then increases production of tyrosinase, the enzyme that drives melanin synthesis, shifting output toward the darker eumelanin pigment type. This cascade is the mechanistic basis for how Melanotan II darkens skin without sun exposure.